Dis-Chem Pharmacies (JSE:DCP) Beneish M-Score: -2.49 (As of Jun. 25, 2026)


JSE:DCP Dis-Chem Pharmacies Ltd JSE:DCP
88 GF Score
Price R33.06
GF Value R38.02
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dis-Chem Pharmacies Beneish M-Score?

Dis-Chem Pharmacies JSE:DCP +0.27% 88 Beneish M-Score is -2.49 as of Jun. 25, 2026. GuruFocus rates JSE:DCP with a GF Score™ of 88/100 and a GF Value™ of R38.02 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks worse than 59.18% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.49 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Dis-Chem Pharmacies's Beneish M-Score or its related term are showing as below:

JSE:DCP' s Beneish M-Score Range Over the Past 10 Years
Min: -2.6   Med: -2.37   Max: -1.81
Current: -2.49

During the past 13 years, the highest Beneish M-Score of Dis-Chem Pharmacies was -1.81. The lowest was -2.60. And the median was -2.37.


Dis-Chem Pharmacies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Dis-Chem Pharmacies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dis-Chem Pharmacies Beneish M-Score Chart

Dis-Chem Pharmacies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.43 -2.37 -2.60 -2.20 -2.49

Dis-Chem Pharmacies Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.60 0.00 -2.20 0.00 -2.49

Dis-Chem Pharmacies Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's Beneish M-Score falls into.


JSE:DCP
88GF Score
Dis-Chem Pharmacies Ltd JSE:DCP
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dis-Chem Pharmacies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Dis-Chem Pharmacies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0466+0.528 * 1.0225+0.404 * 1.1848+0.892 * 1.0933+0.115 * 0.9999
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2199+4.679 * -0.039242-0.327 * 0.9966
=-2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb26) TTM:Last Year (Feb25) TTM:
Total Receivables was R3,692 Mil.
Revenue was R42,826 Mil.
Gross Profit was R9,409 Mil.
Total Current Assets was R12,341 Mil.
Total Assets was R20,738 Mil.
Property, Plant and Equipment(Net PPE) was R5,826 Mil.
Depreciation, Depletion and Amortization(DDA) was R1,260 Mil.
Selling, General, & Admin. Expense(SGA) was R1,442 Mil.
Total Current Liabilities was R11,163 Mil.
Long-Term Debt & Capital Lease Obligation was R3,758 Mil.
Net Income was R979 Mil.
Gross Profit was R0 Mil.
Cash Flow from Operations was R1,793 Mil.
Total Receivables was R3,227 Mil.
Revenue was R39,172 Mil.
Gross Profit was R8,800 Mil.
Total Current Assets was R11,945 Mil.
Total Assets was R19,257 Mil.
Property, Plant and Equipment(Net PPE) was R5,297 Mil.
Depreciation, Depletion and Amortization(DDA) was R1,145 Mil.
Selling, General, & Admin. Expense(SGA) was R1,081 Mil.
Total Current Liabilities was R10,178 Mil.
Long-Term Debt & Capital Lease Obligation was R3,725 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3692.01 / 42825.777) / (3226.639 / 39172.347)
=0.08621 / 0.08237
=1.0466

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8800.375 / 39172.347) / (9409.179 / 42825.777)
=0.224658 / 0.219708
=1.0225

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12341.477 + 5826.232) / 20738.283) / (1 - (11944.913 + 5297.4) / 19256.941)
=0.123953 / 0.104618
=1.1848

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=42825.777 / 39172.347
=1.0933

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1145.229 / (1145.229 + 5297.4)) / (1259.686 / (1259.686 + 5826.232))
=0.177758 / 0.177773
=0.9999

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1442.15 / 42825.777) / (1081.322 / 39172.347)
=0.033675 / 0.027604
=1.2199

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3757.966 + 11163.051) / 20738.283) / ((3724.733 + 10177.823) / 19256.941)
=0.719491 / 0.72195
=0.9966

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(978.894 - 0 - 1792.711) / 20738.283
=-0.039242

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Dis-Chem Pharmacies has a M-score of -2.49 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.49 mean?
Dis-Chem Pharmacies (JSE:DCP) has a Beneish M-Score of -2.49 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dis-Chem Pharmacies and its competitors. According to the industry distribution chart, Dis-Chem Pharmacies ranks #374 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 59.2%.
Is Dis-Chem Pharmacies' Beneish M-Score too high?
Dis-Chem Pharmacies' current Beneish M-Score is -2.49. Based on the distribution chart, Dis-Chem Pharmacies ranks #374 out of 632 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #374 out of 632 companies for Beneish M-Score. This places Dis-Chem Pharmacies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Beneish M-Score is -2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.02, compared to a current price of R33.06 — trading 13% below its estimated fair value. The current Beneish M-Score is -2.49. Dis-Chem Pharmacies' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Beneish M-Score is -2.49 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?

Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R33.06 is trading 13% below its estimated GF Value™ of R38.02. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.

Key valuation signals for JSE:DCP:

  • Beneish M-Score: -2.49
  • GF Value™: R38.02 vs. price of R33.06 (13% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dis-Chem Pharmacies Business Description

Address 23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
88GF Score

Get the complete analysis for JSE:DCP

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R33.06
Price
R38.02
GF Value